The global catheter market size is expected to reach USD 12,591.3 million in 2023. It is anticipated to witness a CAGR of 6.3% in the forecast period from 2023 to 2033.The global catheter market is likely to attain a valuation of USD 23,281.6 million by 2033. It is projected to showcase a valuation of USD 9,621.3 million in the assessment period.
Rising Use of Silicone in Urinary Catheter Development to Spur Demand
The growing adoption of silicone in the development of urinary catheters is expected to create significant opportunities in the catheter market. Silicone is expected to present emerging opportunities in catheter manufacturing. This is due to its insensitivity to temperature variations and chemical resistance, making it highly preferred among patients opting for catheters.
One notable advantage is the potential reduction in complications such as meatitis, urethritis, and trigonitis when using silicone-based urinary catheters. This is estimated to lead to improved patient outcomes and reduced healthcare costs associated with treating catheter-related infections and discomfort.
The need for central venous catheters is projected to increase as the incidence of cancer, cardiovascular disease, and renal illnesses grows in emerging economies. These are expected to provide manufacturers an opportunity to meet these regions' particular requirements. Ongoing technological advancements, including in antimicrobial and biodegradable catheters, are also set to create new opportunities for catheter manufacturers.
| Attributes | Key Insights |
|---|---|
| Catheter Market Estimated Size (2023E) | USD 12,591.3 million |
| Catheter Market Projected Valuation (2033F) | USD 23,281.6 million |
| Value-based Catheter Market CAGR (2023 to 2033) | 6.3% |
| Collective Value Share: Top 5 Countries (2022) | 65.8% |
Controlling Bloodstream Infections Can be a Challenge for Manufacturers
Central venous catheters can carry the risk of causing bloodstream infections as these are used for several medical treatments by inserting them into large central veins. These infections can result in severe complications, prolonged hospitalization, increased healthcare expenses, and even fatalities.
The challenge of preventing and treating bloodstream infections associated with central venous catheters is compounded by antibiotic-resistant pathogens. The overuse and misuse of antibiotics have contributed to the emergence of multidrug-resistant organisms. This makes infections more challenging to control.
In certain instances, the limited effectiveness of antibiotics against specific pathogens can result in treatment failures and complications linked to central line-associated bloodstream infections (CLABSIs). Factors such as high service costs and occasional product recalls are projected to influence the catheter market growth rate negatively.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global catheter market stood at around USD 11930.3 million in 2022. It expanded at a moderate CAGR of 4.7% in terms of volume in the historical period between 2018 and 2022.
| Historical Market Size (2022) | USD 11930.3 million |
|---|---|
| Historical Volume-based CAGR (2023 to 2033) | 4.7% |
The ability of catheters to perform diagnostic procedures, such as hemodialysis and electrophysiological studies, is anticipated to be a key factor driving their demand.
Globally, the increasing incidence of diseases such as cancer, acute illness, and trauma is projected to lead to a surging demand for efficient medical services. It is estimated to result in an increasing usage of peripherally inserted central catheters (PICC) by healthcare professionals in hospitals, operation theaters, and emergency rooms for effective treatment.
About 17.9 million individuals worldwide passed away in 2019 due to cardiovascular diseases, according to the World Health Organization (WHO) figures for 2021. It also found a rise in cardiovascular mortality in poor and moderate-income countries.
High incidence of cancer is set to be a leading driver for PICC usage, as patients undergoing chemotherapy often require long-term venous access. According to the International Agency for Research on Cancer (IARC), there were 19.3 million new cancer cases and 10 million cancer-related deaths worldwide in 2020. Increasing cancer cases worldwide are expected to augment catheter demand through 2033.
With quicker recovery periods, catheterization is projected to be a treatment of choice for several clinical indications. According to a study published in Methodist Debakey Cardiovasc J, the paradigm of open cardiovascular surgeries is shifting toward minimally invasive procedures as more surgeons are adopting less invasive techniques.
Cardiovascular surgeons must stay updated on the most popular minimally invasive and catheter-based techniques. Patients have grown considerably inclined toward these techniques due to the advantages of less blood loss, shorter hospital stays, decreased postoperative pain, and improved cosmesis. These developments are set to make the procedures safe and effective.
The table below provides the latest trends in the global catheter market, growth obstacles, and upcoming opportunities. Choosing appropriate business strategies for the catheter market can enable stakeholders to invest in the right area and gain profit.
| Attributes | Key Factors |
|---|---|
| Latest Trends |
|
| Upcoming Opportunities |
|
| Challenges |
|
Principal Consultant
In the below table of the growth potential of the catheter market, CAGRs of the top 5 countries are provided. Out of the 5, India is likely to lead the catheter market by exhibiting a CAGR of 8.2% from 2023 to 2033. China and Germany are expected to witness catheter sales at the CAGRs of 7.4% and 6.4%, respectively.
Catheter Market Growth Outlook by Key Countries
| Countries | Value-based CAGR |
|---|---|
| United States | 6.0% |
| China | 7.4% |
| Germany | 6.4% |
| United Kingdom | 6.1% |
| India | 8.2% |
The United States catheter market is expected to be highly profitable in the review period. It held a global catheter market share of around 35.2% in 2022. The country will likely register a CAGR of 6.0% during the forecast period.
Growth in the United States is attributed to an extensive healthcare infrastructure, including hospitals, clinics, and research institutions. These facilities are anticipated to create a skyrocketing demand for medical devices such as catheters. The United States is also considered a center for medical innovation and research. It is expected to invest significantly in creating and implementing cutting-edge medical technology.
Innovations include sophisticated catheter designs and materials. It has a robust healthcare infrastructure, substantial healthcare spending, and a keen interest in cutting-edge technology advancements, all of which are expected to aid catheter sales.
China is projected to be one of the most attractive catheter markets globally 2033. It accounted for a steady market share of around 9.7% in 2022. Several factors contribute to significant market growth rates in emerging economies such as China.
Increased healthcare spending in the country is a key driver. Additionally, substantial untapped opportunities in the country are expected to be a key driver.The substantial patient population dealing with kidney and cardiovascular issues, coupled with improvements in healthcare infrastructure, is set to push market expansion in China. Favorable government policies and the increasing introduction of new products are a couple of other factors augmenting demand in the country.
As per a study published in the Clinical Kidney Journal, 88,271 (1.26%) of the 9.5 million people in China had chronic kidney disease (CKD) in December 2022. For stages 3, 4, and 5, the prevalence rates of CKD were 1.20%, 0.04%, and 0.02%, respectively.
The entire incidence rate of CKD was 1.07% after adjusting for the ratio and incidence in urban and rural areas, meaning that around 14 million adults in China suffer from the disease. The frequency of CKD was 1.8 times greater in women than in males, and it increased three times for every decade of age. The country's increasing prevalence of such chronic illnesses is projected to bolster catheter demand through 2033.
India is projected to witness a CAGR of 8.2% from 2023 to 2033 in the catheter market. The pharmaceutical and medical equipment industries in India have expanded dramatically over the past ten years. India is expected to produce a wide range of medical equipment, from implantable to consumable items, including catheters.
In November 2021, for instance, a leading medical technology provider in India, Medtronic, introduced the Arctic Front Cardiac Cryoablation Catheter System for managing atrial fibrillation (AF). To prevent the body from receiving harmful electrical signals, the cryoballoon catheter addresses pulmonary vein isolation, effectively treating AF. Several regulatory agencies have recognized its efficacy and safety, and it is also used to treat more than a million patients worldwide.
In October 2022, on the other hand, DY Patil Medical College opened its advanced bi-plane cardiac catheterization laboratory. It is considered the first-ever model of IGS 6 and catheterization lab in South Asia. It was created in collaboration with Wipro GE Healthcare. Similar innovations in India are anticipated to drive demand for catheters.
Germany is expected to rise at a decent CAGR of about 6.4% in the assessment period in the catheter market. The growing prevalence of cardiovascular conditions and diabetes in the country is projected to aid catheter demand.
According to the German Centers for Health Research, around 8.5 million people in Germany have diabetes. An estimated 2 million people with diabetes have not been diagnosed in the country. In the following twenty years, type 2 diabetes will become more prevalent in Germany. By 2040, up to 12 million individuals could have the metabolic disorder, according to researchers. The increasing prevalence of the disease in the forecast period is set to support demand.
The United Kingdom is estimated to register an average CAGR of 6.1% during the forecast period in the catheter market. Similar to several developed economies, the United Kingdom has a substantial geriatric population.
The country's increasing number of senior citizens will likely pose a high risk of age-related health conditions. Such chronic medical conditions are anticipated to need the intervention of catheters for management, including cardiovascular diseases and urinary incontinence.
According to the National Health Service (NHS), around 3 to 6 million individuals in the United Kingdom suffer from a certain level of urinary incontinence. It is expected to be more common in women than in men.
The table below highlights the global demand for catheters by product. Under products, the intravenous catheter segment will likely remain dominant in the assessment period.
The intravenous catheters segment, while smaller, is set to showcase a significant CAGR of 7.5% through 2033 in the catheter market. It is expected to be followed by urinary catheter and hemodialysis catheter segments.
Catheter Market Growth Outlook by Key Products
| Products | Value-based CAGR |
|---|---|
| Urinary Catheters | 7.0% |
| Intravenous Catheters | 7.5% |
| Hemodialysis Catheters | 5.5% |
The intravenous catheters segment accounted for a dominant share of 64.4% 2022 in the global catheter market. Modern medicine relies heavily on IV catheters as they make it possible to provide patients with fluids, drugs, and nutrition right into their bloodstream. It will likely remain crucial for various medical procedures, such as pain control, chemotherapy, antibiotic therapy, and hydration. Additionally, they are expected to provide accurate and speedy medicine delivery.
Intravenous catheters can deliver drugs more effectively and rapidly than conventional routes, another key factor driving its renown. Furthermore, it is projected that technical advances made by the leading players in this industry will fuel the segment’s growth.
The table below highlights the global demand for catheters by indication. Under indication, the acute kidney injury segment will likely remain dominant in the assessment period.
While smaller, the acute kidney injury segment is set to showcase a significant CAGR of 8.1% through 2033 in the catheter market. It is expected to be followed by urinary incontinence, urethral stricture, chronic obstruction, neurogenic bladder, enlarged prostate gland/BPH, and other segments.
Catheter Market Growth Outlook by Key Indication
| Indication | Value-based CAGR |
|---|---|
| Urinary Incontinence | 6.0% |
| Urethral Stricture | 6.6% |
| Chronic Obstruction | 7.2% |
| Neurogenic Bladder | 7.5% |
| Enlarged Prostate Gland/BPH | 5.3% |
| Prostate Cancer | 5.7% |
| Acute Kidney Injury | 8.1% |
| Others | 4.8% |
Though the acute kidney injury segment is estimated to remain dominant by exhibiting a CAGR of 8.1% in the forecast period, the urinary incontinence segment will likely follow. The latter generated a considerable catheter market share of 24.6% in 2022.
Catheterization, a frequently used medical strategy to effectively control this illness, is set to result in high usage of catheters in treatment of urinary incontinence. By emptying urine from the bladder directly into a collecting bag, catheters are projected to temporarily relieve urinary incontinence in sufferers, thereby driving their demand.
This is considered very helpful for when other procedures or method do not act as effectively. Catheters are expected to provide a dependable method of regulating urine drainage and minimizing leaks for those with severe urinary incontinence.
They are ideal for patients who cannot control their bladder functions owing to neurological problems or other medical concerns. They are also expected to offer several advantages following surgery, including continuous urine drainage.
The table below highlights the global demand for catheters by end-use. Under end-use, the hospital segment will likely remain dominant in the assessment period.
The hospital segment, while smaller, is set to showcase a significant CAGR of 5.7% through 2033 in the catheter market. It is expected to be followed by dialysis centers, long-term care facilities, ambulatory surgical centers, and home care segments.
Catheter Market Growth Outlook by Key End-users
| End-user | Value-based CAGR |
|---|---|
| Hospitals | 5.7% |
| Dialysis Centers | 7.6% |
| Long-term Care Facilities | 6.7% |
| Ambulatory Surgical Centers | 5.1% |
| Home Care | 7.0% |
During the evaluation period, the hospital segment is projected to be a leading end-user in the catheter market. It generated a 48.4% value share in 2022 due to the increasing surgical operations that call for the use of catheters to infuse IV solutions and fluids.
Rising hospital admission rates internationally are also expected to bolster demand. In hospitals, catheter-based procedures are set to guarantee the prompt and precise distribution of drugs.
Catheters are estimated to be essential for patients in critical conditions or those requiring specialized treatments. Additionally, several surgical procedures are set to require catheters, making them unique in hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Prominent players in the catheter market are prioritizing the enhancement of product features as a means to bolster their positions. Additionally, they are keen on extending their presence in emerging markets.
A central strategy embraced by leading manufacturers to maintain leadership in the catheter market involves entering into strategic partnerships and agreements with other companies. These strategies are anticipated to help them in expanding their business reach.
Key players also focus on optimizing their manufacturing processes to reduce manufacturing costs. They are investing considerable sums in advanced supply chain management solutions to lower the total overheads and transportation costs.
For instance,
| Attribute | Details |
|---|---|
| Estimated Catheter Market Size (2023) | USD 12,591.3 million |
| Projected Catheter Market Valuation (2033) | USD 23,281.6 million |
| Value-based Catheter Market CAGR (2023 to 2033) | 6.3% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Catheter Market Analysis | Value (USD million) |
| Key Regions Covered in Catheter Market | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered in Catheter Market | United States, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Segments Covered in Catheter Market | Product, Indication, End-user, and Region |
| Key Companies Profiled in Catheter Market | Becton; Dickinson & Company; Cardinal Health; B. Braun Melsungen AG; Coloplast; Medtronic; ConvaTec Inc.; Teleflex Inc.; Stryker Corporation (Cerus Endovascular); Sterimed Group; VOGT Medical; Optimum Medical Limited; Insung Medical; BACTIGUARD AB; Polymedicure; Utah Medical Products; Inc.; Smiths Medical; Argon Medical Devices; Inc.; Boston Scientific Corporation; Cook Medical Incorporated; Fresenius Kabi AG |
| Catheter Market Report Coverage | Market Forecast, Competition Intelligence, Market Dynamics and Challenges, Strategic Growth Initiatives |
The global catheter market is set to reach USD 23,281.6 million in 2033.
Manufacturers of urinary catheters are expected to use silicone to reduce complications.
Colopast, Medtronic, and Sterimed Group are the leading catheter manufacturers.
Urinary, intravenous, and hemodialysis are the three types of catheters.
The rising demand for minimally invasive surgical procedures is a key trend.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Demand (in Volume) Analysis 2018 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Assessment 8. Global Market Demand (in Value or Size in USD million) Analysis 2018 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 9.1. Urinary Catheters 9.1.1. Foley Catheters 9.1.2. Intermittent Catheters 9.1.3. External Catheters 9.1.4. Compact Catheters 9.2. Intravenous Catheters 9.2.1. Peripheral Catheters 9.2.2. Central Venous Catheters 9.3. Hemodialysis Catheters 9.3.1. Cuffed Tunneled Catheter 9.3.2. Non-cuffed Tunneled Catheters 9.3.3. Non-tunneled Catheters 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 10.1. Urinary Incontinence 10.2. Urethral Stricture 10.3. Chronic Obstruction 10.4. Neurogenic Bladder 10.5. Enlarged Prostate Gland/BPH 10.6. Prostate Cancer 10.7. Acute Kidney Injury 10.8. Others 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user 11.1. Hospitals 11.2. Dialysis Centers 11.3. Long-term Care Facilities 11.4. Ambulatory Surgical Centers 11.5. Home Care 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. South Asia 12.5. East Asia 12.6. Oceania 12.7. Middle East and Africa 13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 20. Market Structure Analysis 21. Competition Analysis 21.1. Becton, Dickinson & Company 21.2. Cardinal Health 21.3. B. Braun Melsungen AG 21.4. Coloplast 21.5. Medtronic 21.6. ConvaTec Inc. 21.7. Teleflex Inc. 21.8. Stryker Corporation (Cerus Endovascular) 21.9. Sterimed Group 21.10. VOGT Medical 21.11. Optimum Medical Limited 21.12. Insung Medical 21.13. BACTIGUARD AB 21.14. Polymedicure 21.15. Utah Medical Products, Inc. 21.16. Smiths Medical 21.17. Argon Medical Devices, Inc. 21.18. Boston Scientific Corporation 21.19. Cook Medical Incorporated 21.20. Fresenius Kabi AG 22. Assumptions and Acronyms Used 23. Research Methodology
Healthcare
June 2023
REP-GB-12575
220 pages
Explore Healthcare Insights
View Reports
Catheter Market
